Troy Cox
CIK 1696923 · View on SEC EDGAR ↗
Insider
First SEC filing: March 18, 2026 · Latest: March 18, 2026
On this page
Insider at
Insider transactions
1 buys (P)
0 sells (S)
Net:
$148,702
+ 23 non-open-market transactions below
Avg return of open purchases vs now:
24.2%
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
23 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 28, 2026 | MPLT | P | 15,620 | $9.52 | $148,702 | 15,620 Indirect | — | Acquired | 24.2% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 23, 2026 | MPLT | Stock Option (right to buy) | Voting Common Stock (29,804) | $28.64 | June 22, 2036 | 29,804 | Acquired |
| June 18, 2026 | LAB | Stock Option (Right to buy) | Common Stock (175,923) | $0.83 | June 18, 2036 | 175,923 | Acquired |
| June 18, 2026 | SOPH | Share Option (Right to Buy) | Ordinary Shares (28,818) | $5.46 | June 18, 2036 | 28,818 | Acquired |
| June 20, 2025 | LAB | Stock Option (Right to buy) | Common Stock (125,660) | $1.05 | June 20, 2035 | 125,660 | Acquired |
| Dec. 10, 2024 | ZYME | Stock Option (Right to Buy) | Common Stock (31,000) | $13.06 | Dec. 9, 2034 | 31,000 | Acquired |
| June 28, 2024 | LAB | Stock Option (Right to buy) | Common Stock (72,213) | $1.77 | June 28, 2034 | 72,213 | Acquired |
| Jan. 5, 2024 | LAB | Warrant to purchase Common Stock (Right to buy) | Common Stock (184,999) | $11.50 | Sept. 1, 2026 | 184,999 | Acquired |
| Jan. 5, 2024 | LAB | Stock Option (Right to buy) | Common Stock (190,365) | $2.08 | March 16, 2033 | 190,365 | Acquired |
| Jan. 5, 2024 | LAB | Stock Option (Right to buy) | Common Stock (928,811) | $2.60 | Oct. 16, 2032 | 982,811 | Acquired |
| Jan. 5, 2024 | LAB | Stock Option (Right to buy) | Common Stock (22,866) | $8.18 | Feb. 29, 2032 | 22,866 | Acquired |
| Jan. 5, 2024 | LAB | Stock Option (Right to buy) | Common Stock (51,842) | $10.68 | Oct. 26, 2031 | 51,842 | Acquired |
| Dec. 7, 2023 | ZYME | Stock Option (Right to Buy) | Common Stock (37,000) | $9.55 | Dec. 6, 2033 | 37,000 | Acquired |
| Dec. 21, 2022 | ZYME | Stock Option (Right to Buy) | Common Stock (25,000) | $8.75 | Dec. 20, 2032 | 25,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 18, 2026 | SOPH | Ordinary Shares | 309,019 | Direct |
| March 18, 2026 | SOPH | Share Option (Right to Buy)→ Ordinary Shares (11,500) | 11,500 | Direct |
| March 18, 2026 | SOPH | Share Option (Right to Buy)→ Ordinary Shares (162,740) | 162,740 | Direct |
| March 18, 2026 | SOPH | Share Option (Right to Buy)→ Ordinary Shares (49,751) | 49,751 | Direct |